nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—Balsalazide—Crohn's disease	0.23	0.308	CbGbCtD
Nateglinide—PPARG—Mesalazine—Crohn's disease	0.184	0.246	CbGbCtD
Nateglinide—ALB—Crohn's disease	0.179	1	CbGaD
Nateglinide—PPARG—Sulfasalazine—Crohn's disease	0.103	0.138	CbGbCtD
Nateglinide—ABCC4—Mercaptopurine—Crohn's disease	0.0639	0.0857	CbGbCtD
Nateglinide—PTGS1—Balsalazide—Crohn's disease	0.0579	0.0776	CbGbCtD
Nateglinide—PTGS1—Mesalazine—Crohn's disease	0.0463	0.0621	CbGbCtD
Nateglinide—PTGS1—Sulfasalazine—Crohn's disease	0.0259	0.0347	CbGbCtD
Nateglinide—CYP3A5—Sulfasalazine—Crohn's disease	0.0155	0.0208	CbGbCtD
Nateglinide—ALB—Prednisone—Crohn's disease	0.0154	0.0207	CbGbCtD
Nateglinide—ABCC8—penis—Crohn's disease	0.00591	0.174	CbGeAlD
Nateglinide—ORM1—bile—Crohn's disease	0.0059	0.174	CbGeAlD
Nateglinide—CYP3A4—Prednisone—Crohn's disease	0.00484	0.00649	CbGbCtD
Nateglinide—PPARG—Methyldopa—Mesalazine—Crohn's disease	0.00185	1	CbGdCrCtD
Nateglinide—Hepatitis cholestatic—Mesalazine—Crohn's disease	0.00167	0.0688	CcSEcCtD
Nateglinide—ORM1—gall bladder—Crohn's disease	0.00164	0.0483	CbGeAlD
Nateglinide—ALB—gall bladder—Crohn's disease	0.00144	0.0423	CbGeAlD
Nateglinide—UGT1A9—digestive system—Crohn's disease	0.00122	0.0361	CbGeAlD
Nateglinide—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.00115	0.0471	CcSEcCtD
Nateglinide—SLC15A2—mouth—Crohn's disease	0.00107	0.0314	CbGeAlD
Nateglinide—ABCC8—smooth muscle tissue—Crohn's disease	0.001	0.0295	CbGeAlD
Nateglinide—SLC15A1—epithelium—Crohn's disease	0.000992	0.0292	CbGeAlD
Nateglinide—SLC16A1—epithelium—Crohn's disease	0.000944	0.0278	CbGeAlD
Nateglinide—KCNJ11—lymphoid tissue—Crohn's disease	0.000867	0.0256	CbGeAlD
Nateglinide—SLC15A1—mammalian vulva—Crohn's disease	0.00086	0.0254	CbGeAlD
Nateglinide—PPARG—epithelium—Crohn's disease	0.000792	0.0233	CbGeAlD
Nateglinide—PPARG—smooth muscle tissue—Crohn's disease	0.000763	0.0225	CbGeAlD
Nateglinide—SLC15A1—digestive system—Crohn's disease	0.000754	0.0222	CbGeAlD
Nateglinide—PPARG—skin of body—Crohn's disease	0.000753	0.0222	CbGeAlD
Nateglinide—Trauma—Prednisone—Crohn's disease	0.000748	0.0308	CcSEcCtD
Nateglinide—Arthropathy—Mesalazine—Crohn's disease	0.00074	0.0305	CcSEcCtD
Nateglinide—SLC16A1—digestive system—Crohn's disease	0.000718	0.0212	CbGeAlD
Nateglinide—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.000712	0.0293	CcSEcCtD
Nateglinide—PPARG—mammalian vulva—Crohn's disease	0.000687	0.0202	CbGeAlD
Nateglinide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000656	0.027	CcSEcCtD
Nateglinide—PPARG—lymphoid tissue—Crohn's disease	0.00061	0.018	CbGeAlD
Nateglinide—PPARG—digestive system—Crohn's disease	0.000602	0.0178	CbGeAlD
Nateglinide—Immune system disorder—Mercaptopurine—Crohn's disease	0.000563	0.0232	CcSEcCtD
Nateglinide—ABCC4—digestive system—Crohn's disease	0.000547	0.0161	CbGeAlD
Nateglinide—Malnutrition—Mercaptopurine—Crohn's disease	0.000542	0.0223	CcSEcCtD
Nateglinide—Increased appetite—Mesalazine—Crohn's disease	0.00052	0.0214	CcSEcCtD
Nateglinide—Thirst—Mesalazine—Crohn's disease	0.000514	0.0211	CcSEcCtD
Nateglinide—KCNJ11—lymph node—Crohn's disease	0.000489	0.0144	CbGeAlD
Nateglinide—Osteoarthritis—Mesalazine—Crohn's disease	0.000489	0.0201	CcSEcCtD
Nateglinide—PTGS1—epithelium—Crohn's disease	0.000423	0.0125	CbGeAlD
Nateglinide—Influenza—Mesalazine—Crohn's disease	0.000422	0.0174	CcSEcCtD
Nateglinide—SLC16A1—lymph node—Crohn's disease	0.00041	0.0121	CbGeAlD
Nateglinide—PTGS1—smooth muscle tissue—Crohn's disease	0.000408	0.012	CbGeAlD
Nateglinide—Bronchitis—Mesalazine—Crohn's disease	0.000406	0.0167	CcSEcCtD
Nateglinide—PTGS1—skin of body—Crohn's disease	0.000403	0.0119	CbGeAlD
Nateglinide—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000393	0.0162	CcSEcCtD
Nateglinide—Arthropathy—Prednisone—Crohn's disease	0.000392	0.0161	CcSEcCtD
Nateglinide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000391	0.0161	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000382	0.0157	CcSEcCtD
Nateglinide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000369	0.0152	CcSEcCtD
Nateglinide—ORM1—lymph node—Crohn's disease	0.000368	0.0108	CbGeAlD
Nateglinide—PTGS1—mammalian vulva—Crohn's disease	0.000367	0.0108	CbGeAlD
Nateglinide—Jaundice—Mesalazine—Crohn's disease	0.000367	0.0151	CcSEcCtD
Nateglinide—Sweating—Mesalazine—Crohn's disease	0.000361	0.0149	CcSEcCtD
Nateglinide—CYP3A5—digestive system—Crohn's disease	0.000358	0.0106	CbGeAlD
Nateglinide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000356	0.0147	CcSEcCtD
Nateglinide—CYP2C9—digestive system—Crohn's disease	0.000353	0.0104	CbGeAlD
Nateglinide—Erythema multiforme—Azathioprine—Crohn's disease	0.000351	0.0145	CcSEcCtD
Nateglinide—PPARG—lymph node—Crohn's disease	0.000344	0.0101	CbGeAlD
Nateglinide—Amphetamine—SLC22A5—Crohn's disease	0.000343	0.519	CrCbGaD
Nateglinide—Immune system disorder—Azathioprine—Crohn's disease	0.000335	0.0138	CcSEcCtD
Nateglinide—Oedema peripheral—Mesalazine—Crohn's disease	0.000333	0.0137	CcSEcCtD
Nateglinide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000326	0.0134	CcSEcCtD
Nateglinide—ALB—lymph node—Crohn's disease	0.000323	0.00951	CbGeAlD
Nateglinide—PTGS1—digestive system—Crohn's disease	0.000322	0.00949	CbGeAlD
Nateglinide—Erythema multiforme—Mesalazine—Crohn's disease	0.00032	0.0132	CcSEcCtD
Nateglinide—Methamphetamine—SLC22A5—Crohn's disease	0.000317	0.481	CrCbGaD
Nateglinide—ABCC4—lymph node—Crohn's disease	0.000312	0.00921	CbGeAlD
Nateglinide—Immune system disorder—Mesalazine—Crohn's disease	0.000305	0.0126	CcSEcCtD
Nateglinide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000303	0.0125	CcSEcCtD
Nateglinide—Back pain—Mesalazine—Crohn's disease	0.000285	0.0117	CcSEcCtD
Nateglinide—Vomiting—Mercaptopurine—Crohn's disease	0.000281	0.0116	CcSEcCtD
Nateglinide—Injury—Prednisone—Crohn's disease	0.000281	0.0116	CcSEcCtD
Nateglinide—Rash—Mercaptopurine—Crohn's disease	0.000279	0.0115	CcSEcCtD
Nateglinide—Dermatitis—Mercaptopurine—Crohn's disease	0.000279	0.0115	CcSEcCtD
Nateglinide—Tremor—Mesalazine—Crohn's disease	0.000276	0.0114	CcSEcCtD
Nateglinide—Increased appetite—Prednisone—Crohn's disease	0.000275	0.0113	CcSEcCtD
Nateglinide—SLC15A2—lymph node—Crohn's disease	0.000269	0.00794	CbGeAlD
Nateglinide—CYP3A4—digestive system—Crohn's disease	0.000269	0.00793	CbGeAlD
Nateglinide—CYP2D6—digestive system—Crohn's disease	0.000265	0.0078	CbGeAlD
Nateglinide—Nausea—Mercaptopurine—Crohn's disease	0.000263	0.0108	CcSEcCtD
Nateglinide—Palpitations—Mesalazine—Crohn's disease	0.00026	0.0107	CcSEcCtD
Nateglinide—Osteoarthritis—Prednisone—Crohn's disease	0.000259	0.0106	CcSEcCtD
Nateglinide—Cough—Mesalazine—Crohn's disease	0.000257	0.0106	CcSEcCtD
Nateglinide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000232	0.00956	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000228	0.00937	CcSEcCtD
Nateglinide—Sweating increased—Prednisone—Crohn's disease	0.000218	0.00896	CcSEcCtD
Nateglinide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000216	0.00888	CcSEcCtD
Nateglinide—Dyspepsia—Mesalazine—Crohn's disease	0.000211	0.00871	CcSEcCtD
Nateglinide—Abdominal pain—Azathioprine—Crohn's disease	0.000208	0.00858	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000207	0.00854	CcSEcCtD
Nateglinide—Fatigue—Mesalazine—Crohn's disease	0.000207	0.00853	CcSEcCtD
Nateglinide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000196	0.00809	CcSEcCtD
Nateglinide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000195	0.00804	CcSEcCtD
Nateglinide—Hypersensitivity—Azathioprine—Crohn's disease	0.000194	0.008	CcSEcCtD
Nateglinide—Urticaria—Mesalazine—Crohn's disease	0.000191	0.00786	CcSEcCtD
Nateglinide—Abdominal pain—Mesalazine—Crohn's disease	0.00019	0.00782	CcSEcCtD
Nateglinide—PTGS1—lymph node—Crohn's disease	0.000184	0.00542	CbGeAlD
Nateglinide—Diarrhoea—Azathioprine—Crohn's disease	0.00018	0.00743	CcSEcCtD
Nateglinide—Hypersensitivity—Mesalazine—Crohn's disease	0.000177	0.00729	CcSEcCtD
Nateglinide—Dizziness—Azathioprine—Crohn's disease	0.000174	0.00718	CcSEcCtD
Nateglinide—Asthenia—Mesalazine—Crohn's disease	0.000172	0.0071	CcSEcCtD
Nateglinide—Pruritus—Mesalazine—Crohn's disease	0.00017	0.007	CcSEcCtD
Nateglinide—Vomiting—Azathioprine—Crohn's disease	0.000168	0.0069	CcSEcCtD
Nateglinide—Rash—Azathioprine—Crohn's disease	0.000166	0.00685	CcSEcCtD
Nateglinide—Dermatitis—Azathioprine—Crohn's disease	0.000166	0.00684	CcSEcCtD
Nateglinide—Diarrhoea—Mesalazine—Crohn's disease	0.000164	0.00677	CcSEcCtD
Nateglinide—Immune system disorder—Prednisone—Crohn's disease	0.000162	0.00665	CcSEcCtD
Nateglinide—Dizziness—Mesalazine—Crohn's disease	0.000159	0.00654	CcSEcCtD
Nateglinide—Nausea—Azathioprine—Crohn's disease	0.000157	0.00645	CcSEcCtD
Nateglinide—Malnutrition—Prednisone—Crohn's disease	0.000156	0.00641	CcSEcCtD
Nateglinide—Vomiting—Mesalazine—Crohn's disease	0.000153	0.00629	CcSEcCtD
Nateglinide—Rash—Mesalazine—Crohn's disease	0.000151	0.00624	CcSEcCtD
Nateglinide—Dermatitis—Mesalazine—Crohn's disease	0.000151	0.00623	CcSEcCtD
Nateglinide—Nausea—Mesalazine—Crohn's disease	0.000143	0.00587	CcSEcCtD
Nateglinide—Hyperhidrosis—Prednisone—Crohn's disease	0.000123	0.00506	CcSEcCtD
Nateglinide—Dyspepsia—Prednisone—Crohn's disease	0.000112	0.00461	CcSEcCtD
Nateglinide—Fatigue—Prednisone—Crohn's disease	0.00011	0.00451	CcSEcCtD
Nateglinide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000104	0.00428	CcSEcCtD
Nateglinide—Urticaria—Prednisone—Crohn's disease	0.000101	0.00416	CcSEcCtD
Nateglinide—Abdominal pain—Prednisone—Crohn's disease	0.0001	0.00414	CcSEcCtD
Nateglinide—Hypersensitivity—Prednisone—Crohn's disease	9.36e-05	0.00386	CcSEcCtD
Nateglinide—Asthenia—Prednisone—Crohn's disease	9.12e-05	0.00375	CcSEcCtD
Nateglinide—Pruritus—Prednisone—Crohn's disease	8.99e-05	0.0037	CcSEcCtD
Nateglinide—Diarrhoea—Prednisone—Crohn's disease	8.7e-05	0.00358	CcSEcCtD
Nateglinide—Dizziness—Prednisone—Crohn's disease	8.4e-05	0.00346	CcSEcCtD
Nateglinide—Vomiting—Prednisone—Crohn's disease	8.08e-05	0.00333	CcSEcCtD
Nateglinide—Rash—Prednisone—Crohn's disease	8.01e-05	0.0033	CcSEcCtD
Nateglinide—Dermatitis—Prednisone—Crohn's disease	8.01e-05	0.0033	CcSEcCtD
Nateglinide—Nausea—Prednisone—Crohn's disease	7.55e-05	0.00311	CcSEcCtD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.9e-05	0.00411	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.9e-05	0.00411	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	5.85e-05	0.00408	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.64e-05	0.00393	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.64e-05	0.00393	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—SOCS1—Crohn's disease	5.62e-05	0.00392	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.31e-05	0.0037	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.31e-05	0.0037	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.23e-05	0.00365	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	5.21e-05	0.00364	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.07e-05	0.00354	CbGpPWpGaD
Nateglinide—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	5.05e-05	0.00352	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	4.95e-05	0.00345	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.93e-05	0.00344	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.93e-05	0.00344	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—SMAD3—Crohn's disease	4.85e-05	0.00338	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—F5—Crohn's disease	4.81e-05	0.00335	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—ALB—Crohn's disease	4.76e-05	0.00332	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	4.54e-05	0.00316	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.49e-05	0.00313	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.48e-05	0.00313	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.44e-05	0.0031	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	4.35e-05	0.00303	CbGpPWpGaD
Nateglinide—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.27e-05	0.00298	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.2e-05	0.00293	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.2e-05	0.00293	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL3—Crohn's disease	4.17e-05	0.00291	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.15e-05	0.0029	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	4.12e-05	0.00287	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	4.05e-05	0.00283	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	4.03e-05	0.00281	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	4.03e-05	0.00281	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.97e-05	0.00277	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—PTRF—Crohn's disease	3.95e-05	0.00275	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.82e-05	0.00266	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	3.78e-05	0.00264	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.74e-05	0.00261	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.74e-05	0.00261	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.74e-05	0.00261	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.73e-05	0.0026	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	3.7e-05	0.00258	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.67e-05	0.00256	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.66e-05	0.00255	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.66e-05	0.00255	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.66e-05	0.00255	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—STAT3—Crohn's disease	3.64e-05	0.00254	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—F5—Crohn's disease	3.59e-05	0.0025	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.51e-05	0.00245	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.47e-05	0.00242	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.46e-05	0.00241	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.31e-05	0.00231	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—CRP—Crohn's disease	3.28e-05	0.00229	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PLA2G4F—Crohn's disease	3.25e-05	0.00227	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.24e-05	0.00226	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PLA2G4F—Crohn's disease	3.15e-05	0.0022	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	3.15e-05	0.00219	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—Crohn's disease	3.15e-05	0.00219	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.11e-05	0.00217	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	3.11e-05	0.00217	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PLA2G4F—Crohn's disease	3.1e-05	0.00216	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	3.09e-05	0.00216	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.07e-05	0.00214	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.07e-05	0.00214	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—ICAM1—Crohn's disease	3.01e-05	0.0021	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.98e-05	0.00207	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.96e-05	0.00206	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ITGA4—Crohn's disease	2.96e-05	0.00206	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	2.92e-05	0.00204	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	2.92e-05	0.00203	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL3—Crohn's disease	2.88e-05	0.00201	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	2.84e-05	0.00198	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	2.82e-05	0.00197	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—RASGRP1—Crohn's disease	2.79e-05	0.00194	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.79e-05	0.00194	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—MTMR3—Crohn's disease	2.76e-05	0.00193	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.72e-05	0.0019	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—MTMR3—Crohn's disease	2.68e-05	0.00187	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—MTMR3—Crohn's disease	2.64e-05	0.00184	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.64e-05	0.00184	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.62e-05	0.00182	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	2.6e-05	0.00182	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.58e-05	0.0018	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	2.53e-05	0.00176	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	2.51e-05	0.00175	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.49e-05	0.00173	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	2.48e-05	0.00173	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.43e-05	0.00169	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.39e-05	0.00167	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ZFP36L1—Crohn's disease	2.37e-05	0.00165	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.35e-05	0.00164	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.34e-05	0.00163	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.33e-05	0.00163	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PLA2G4F—Crohn's disease	2.33e-05	0.00162	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IFNG—Crohn's disease	2.29e-05	0.0016	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.28e-05	0.00159	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.27e-05	0.00158	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.25e-05	0.00157	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—STAT3—Crohn's disease	2.22e-05	0.00154	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ITGA4—Crohn's disease	2.2e-05	0.00154	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.17e-05	0.00152	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—FADS1—Crohn's disease	2.15e-05	0.0015	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL3—Crohn's disease	2.15e-05	0.0015	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	2.11e-05	0.00147	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—FADS1—Crohn's disease	2.09e-05	0.00146	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—RASGRP1—Crohn's disease	2.08e-05	0.00145	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—FADS1—Crohn's disease	2.06e-05	0.00143	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL1B—Crohn's disease	2.05e-05	0.00143	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	2.02e-05	0.00141	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL2RA—Crohn's disease	2.02e-05	0.00141	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GPX4—Crohn's disease	2.01e-05	0.00141	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—DNMT3A—Crohn's disease	2.01e-05	0.0014	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	2e-05	0.00139	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2e-05	0.00139	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTMR3—Crohn's disease	1.98e-05	0.00138	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.96e-05	0.00137	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GPX4—Crohn's disease	1.95e-05	0.00136	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GCKR—Crohn's disease	1.95e-05	0.00136	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GPX4—Crohn's disease	1.93e-05	0.00134	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.93e-05	0.00134	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TNF—Crohn's disease	1.92e-05	0.00134	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.9e-05	0.00133	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.9e-05	0.00133	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GCKR—Crohn's disease	1.89e-05	0.00132	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	1.89e-05	0.00132	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GCKR—Crohn's disease	1.86e-05	0.0013	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.84e-05	0.00128	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	1.82e-05	0.00127	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	1.82e-05	0.00127	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	1.82e-05	0.00127	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—SMAD3—Crohn's disease	1.77e-05	0.00123	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.75e-05	0.00122	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTMR3—Crohn's disease	1.7e-05	0.00119	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	1.68e-05	0.00117	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SMAD3—Crohn's disease	1.67e-05	0.00116	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.64e-05	0.00114	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.63e-05	0.00114	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.62e-05	0.00113	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—F5—Crohn's disease	1.62e-05	0.00113	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.61e-05	0.00113	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.56e-05	0.00109	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IL6—Crohn's disease	1.55e-05	0.00108	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—FADS1—Crohn's disease	1.54e-05	0.00108	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL2RA—Crohn's disease	1.51e-05	0.00105	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TNF—Crohn's disease	1.48e-05	0.00103	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.48e-05	0.00103	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.47e-05	0.00103	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ALB—Crohn's disease	1.46e-05	0.00102	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.46e-05	0.00102	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GPX4—Crohn's disease	1.44e-05	0.00101	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTMR3—Crohn's disease	1.43e-05	0.000998	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GCKR—Crohn's disease	1.39e-05	0.000972	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTMR3—Crohn's disease	1.39e-05	0.000967	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—HSPA1B—Crohn's disease	1.36e-05	0.000948	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—JAK2—Crohn's disease	1.36e-05	0.000946	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.34e-05	0.000934	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—FADS1—Crohn's disease	1.33e-05	0.000924	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.32e-05	0.000922	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.32e-05	0.000922	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.28e-05	0.000889	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.26e-05	0.000881	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GPX4—Crohn's disease	1.24e-05	0.000865	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	1.22e-05	0.000848	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GCKR—Crohn's disease	1.2e-05	0.000836	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL6—Crohn's disease	1.2e-05	0.000835	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.19e-05	0.000833	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—UBE2D1—Crohn's disease	1.19e-05	0.000831	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-05	0.00083	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.18e-05	0.000826	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.18e-05	0.000822	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—FADS1—Crohn's disease	1.11e-05	0.000777	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.1e-05	0.000771	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—IL6—Crohn's disease	1.09e-05	0.000762	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ALB—Crohn's disease	1.09e-05	0.000759	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TYK2—Crohn's disease	1.09e-05	0.000758	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—FADS1—Crohn's disease	1.08e-05	0.000753	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLA2G4F—Crohn's disease	1.05e-05	0.00073	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000728	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—JAK2—Crohn's disease	1.04e-05	0.000723	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTMR3—Crohn's disease	1.03e-05	0.000721	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—JAK2—Crohn's disease	1.01e-05	0.000706	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPX4—Crohn's disease	1.01e-05	0.000705	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GCKR—Crohn's disease	1.01e-05	0.000703	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ITGA4—Crohn's disease	9.97e-06	0.000695	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.97e-06	0.000695	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GCKR—Crohn's disease	9.77e-06	0.000681	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL3—Crohn's disease	9.73e-06	0.000678	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	9.51e-06	0.000663	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	9.42e-06	0.000657	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RASGRP1—Crohn's disease	9.41e-06	0.000656	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTMR3—Crohn's disease	8.91e-06	0.000621	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	8.88e-06	0.000619	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.72e-06	0.000608	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	8.65e-06	0.000603	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	8.57e-06	0.000598	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.56e-06	0.000597	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SMAD3—Crohn's disease	8.53e-06	0.000595	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	8.2e-06	0.000572	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—FADS1—Crohn's disease	8.06e-06	0.000562	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—STAT3—Crohn's disease	7.61e-06	0.000531	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX4—Crohn's disease	7.54e-06	0.000526	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.49e-06	0.000522	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.35e-06	0.000513	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTMR3—Crohn's disease	7.29e-06	0.000508	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GCKR—Crohn's disease	7.29e-06	0.000508	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.98e-06	0.000487	CbGpPWpGaD
Nateglinide—ALB—Metabolism—FADS1—Crohn's disease	6.94e-06	0.000484	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2RA—Crohn's disease	6.81e-06	0.000475	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—Crohn's disease	6.59e-06	0.00046	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX4—Crohn's disease	6.5e-06	0.000453	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GCKR—Crohn's disease	6.27e-06	0.000438	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—Crohn's disease	6.19e-06	0.000432	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.11e-06	0.000426	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—Crohn's disease	6.01e-06	0.000419	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—Crohn's disease	5.92e-06	0.000413	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—FADS1—Crohn's disease	5.73e-06	0.000399	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—FADS1—Crohn's disease	5.68e-06	0.000396	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.65e-06	0.000394	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—Crohn's disease	5.42e-06	0.000378	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX4—Crohn's disease	5.36e-06	0.000374	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—Crohn's disease	5.32e-06	0.000371	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX4—Crohn's disease	5.32e-06	0.000371	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—Crohn's disease	5.25e-06	0.000366	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCKR—Crohn's disease	5.18e-06	0.000361	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—Crohn's disease	5.18e-06	0.000361	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCKR—Crohn's disease	5.14e-06	0.000358	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.81e-06	0.000335	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—JAK2—Crohn's disease	4.58e-06	0.000319	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—Crohn's disease	4.44e-06	0.00031	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.92e-06	0.000274	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—Crohn's disease	3.88e-06	0.000271	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—Crohn's disease	3.81e-06	0.000266	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FADS1—Crohn's disease	3.75e-06	0.000261	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.67e-06	0.000256	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX4—Crohn's disease	3.51e-06	0.000245	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCKR—Crohn's disease	3.39e-06	0.000236	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—Crohn's disease	3.34e-06	0.000233	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.21e-06	0.000224	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—Crohn's disease	3.21e-06	0.000224	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—Crohn's disease	3.11e-06	0.000217	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—Crohn's disease	2.81e-06	0.000196	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—Crohn's disease	2.72e-06	0.00019	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—Crohn's disease	2.32e-06	0.000162	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.03e-06	0.000141	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—Crohn's disease	1.75e-06	0.000122	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—Crohn's disease	1.65e-06	0.000115	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—Crohn's disease	1.63e-06	0.000114	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.44e-06	0.000101	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.43e-06	9.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—Crohn's disease	1.08e-06	7.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—Crohn's disease	9.43e-07	6.58e-05	CbGpPWpGaD
